DALLAS, Texas, June 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- North American Cannabis Holdings, Inc. (USMJ) (“USMJâ€) today announced a three-year contract with Kali-Extracts, Inc. (KALY) (“KALYâ€) to manage the production and distribution of KALY’s Hemp4mula CBD Infused Candies. After years of cannabis sector business incubation, USMJ transitioned late last year into focusing on cannabis sector logistics services. To demonstrate the caliber of their logistics capabilities, the company launched its www.USMJ.com Ecommerce site. Hemp4mula is currently available for sale on the USMJ Ecommerce site. Now USMJ will provide a more comprehensive array of services to KALY managing the Hemp4mula line from inception through distribution and in some cases, through end sales.
KALY owns and operates a U.S. Patented Cannabis
Extraction Process. KALY is primarily a biopharmaceutical
company focused on discovering, developing and commercializing
novel therapeutics from a proprietary cannabinoid product platform
in a broad range of disease areas. KALY has completed the
first stage of clinical development and testing for a Chronic
Obstructive Pulmonary Disease (COPD) therapy and is currently
conducting phase one development and trials for compounds targeting
Cancer Pain Management, Type 2 Diabetes and Epilepsy.
KALY is not relying on its biopharmaceutical development strategy
alone to insure the company’s long-term success. With the
popularity of cannabis extracts for infusion into various consumer
products, KALY’s patented extraction process offers arguably the
highest quality extract to the infusion market. Drawing on
KALY’s patented cannabis extraction expertise, in addition to
recently winning a $5 million
extraction contract, KALY has partnered with Puration
(PURA) to lend its extraction expertise in
the production of EVERx CBD Sports Water, the leading CBD infused
beverage for the sports nutrition market. KALY has also
introduced its own CBD confections line, Hemp4mula with CBD infused
gum already on the market and gummies on the way.
To learn more visit www.USMJ.com and
www.GrowUSMJ.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure, or prevent any
disease.
Steven Rash
CEO North American Cannabis Holdings, Inc.
[email protected]
+1-800-861-1350